>
>
Cholera Vaccines Market - By Product (Dukoral, Vaxchora, Euvichol/Euvichol-Plus), End-user (Public, Private) – Global Forecast (2024 – 2032)
Download Free PDF

Cholera Vaccines Market
Get a free sample of this reportGet a free sample of this report Cholera Vaccines Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 9
Tables & Figures: 311
Countries covered: 24
Pages: 160
Download Free PDF
Cholera Vaccines Market Size
Cholera Vaccines Market size was valued at USD 89.4 million in 2023 and is estimated to grow at 8.4% CAGR from 2024 to 2032, due to the growing global burden of cholera outbreak, especially in areas with insufficient water and sanitation infrastructure.
For instance, according to the World Health Organization (WHO), there are 1.4 to 4.3 million cholera cases and up to 143,000 deaths annually, with a disproportionate burden in Africa and South Asia. This significant impact emphasized the urgent need for effective vaccination programs and prevention strategies, thereby expanding the market growth.
Additionally, growing awareness and initiatives by governments and international organizations to implement mass vaccination campaigns has fostered the market demand. Furthermore, the rising travel to endemic areas also boosts demand for cholera vaccines, as does the development of more accessible and affordable travel vaccine formulations, which enhance immunization efforts and market penetration.
Cholera vaccines are biological preparations used to provide active immunity against cholera, an acute diarrheal disease caused by the bacterium Vibrio cholerae. These vaccines are designed to stimulate the body's immune response to prevent the onset of the disease upon exposure to the pathogen.
Cholera Vaccines Market Trends
The growing government and organizations support & initiatives tend to propel the market growth by primarily facilitating mass vaccination campaigns particularly in high-risk areas to enhance the accessibility and distribution of cholera vaccines to address global needs. These collaborative efforts aimed to raise public awareness pertaining to the importance of cholera immunization, while also providing essential funding, technical assistance, and resources to enable the effective implementation of vaccination programs in underdeveloped areas, thereby driving the market demand.
Moreover, increasing research funding, and strategic approaches by key players focusing on the development, production, and distribution of cholera vaccines to vulnerable populations explore significant market opportunities.
Cholera Vaccines Market Analysis
Based on the product, the market is categorized as Dukoral, Vaxchora, Euvichol/Euvichol-Plus, and other products. The Euvichol/Euvichol-Plus product segment is set to lead the market, accounting for the largest revenue of USD 40.4 million in 2023, anticipating its dominance throughout the forecast period with a CAGR of 8.2%.
Based on end-user, the cholera vaccines market is classified into Public and private. The public segment holds the largest market share of 80.8% in 2023 and is expected to maintain dominance throughout the analysis period.
Canada dominated the North American cholera vaccines market accounting for USD 19.3 million in 2023 and is anticipated to show considerable growth over the analysis period.
The UK exhibited a high growth potential in the European cholera vaccines market.
The Asia Pacific leads the cholera vaccines market with a share of 41.5% in 2023 poised to grow with a CAGR of 8.7%.
Cholera Vaccines Market Share
The cholera vaccine market is fiercely competitive with numerous pharmaceutical and biotech companies vying for dominance. These companies are at the forefront of developing cutting-edge vaccine formulations, boosting production capabilities, and extending their global distribution networks. They strategically collaborate with research institutions and international bodies to strengthen research and development initiatives and expedite regulatory approvals. Additionally, significant investments in advanced vaccine technologies underscore their commitment to meeting the increasing demand for efficient cholera prevention measures in high-risk areas globally.
Cholera Vaccines Market Companies
The company profile section include both companies that have commercial drug available in market as well as those that are onto clinical phase development. Few of the prominent players operating in the cholera vaccines industry include:
Cholera Vaccines Industry News:
The cholera vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By End-user
The above information is provided for the following regions and countries: